United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Jul 31, 2026 · Filed Aug 3, 2026

On Jul 31, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$518.96 for US$4.93M under a trading plan, leaving 324,443 shares. Filed Aug 3, 2026 (Form 4).

Sold
9,500 shares
Price
US$518.96 average (US$514.82 to US$522.88)
Value
US$4.93M
Holding after
324,443 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 31, 2026Common StockOption exercise9,500US$135.42333,943Indirect
Jul 31, 2026Common StockSale365US$514.82333,578Indirect
Jul 31, 2026Common StockSale857US$515.84332,721Indirect
Jul 31, 2026Common StockSale1,133US$516.94331,588Indirect
Jul 31, 2026Common StockSale1,215US$518.00330,373Indirect
Jul 31, 2026Common StockSale1,266US$519.06329,107Indirect
Jul 31, 2026Common StockSale2,627US$520.12326,480Indirect
Jul 31, 2026Common StockSale1,517US$520.80324,963Indirect
Jul 31, 2026Common StockSale282US$521.52324,681Indirect
Jul 31, 2026Common StockSale238US$522.88324,443Indirect

Source

View original at SEC

Related